These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26692193)

  • 1. Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection.
    Krause A; Zisowsky J; Strasser DS; Gehin M; Sidharta PN; Groenen PMA; Dingemanse J
    Clin Pharmacokinet; 2016 Jul; 55(7):813-821. PubMed ID: 26692193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CRTH2 antagonist: Single- and multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ACT-453859 in healthy subjects.
    Géhin M; Strasser DS; Zisowsky J; Farine H; Groenen PM; Dingemanse J; Sidharta PN
    J Clin Pharmacol; 2015 Jul; 55(7):787-97. PubMed ID: 25655470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects.
    Sidharta PN; Diamant Z; Dingemanse J
    Fundam Clin Pharmacol; 2014 Dec; 28(6):690-9. PubMed ID: 24734908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
    Sykes DA; Bradley ME; Riddy DM; Willard E; Reilly J; Miah A; Bauer C; Watson SJ; Sandham DA; Dubois G; Charlton SJ
    Mol Pharmacol; 2016 May; 89(5):593-605. PubMed ID: 26916831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
    Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
    Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
    Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
    J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, pharmacodynamics, tolerability and prediction of clinically effective dose of ACT-774312: A novel CRTH2 antagonist.
    Géhin M; Lott D; Farine H; Issac M; Strasser D; Sidharta P; Dingemanse J
    Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):711-721. PubMed ID: 30589994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of CRTh2 antagonist LAS191859: Long receptor residence time translates into long-lasting in vivo efficacy.
    Calbet M; Andrés M; Armengol C; Bravo M; Eichhorn P; López R; García-González V; Roberts R; Miralpeix M
    Pharmacol Res; 2016 Sep; 111():208-216. PubMed ID: 27317944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonist.
    Fretz H; Valdenaire A; Pothier J; Hilpert K; Gnerre C; Peter O; Leroy X; Riederer MA
    J Med Chem; 2013 Jun; 56(12):4899-911. PubMed ID: 23721423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
    Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
    Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma.
    Fowler A; Koenen R; Hilbert J; Blatchford J; Kappeler D; Benediktus E; Wood C; Gupta A
    J Clin Pharmacol; 2017 Nov; 57(11):1444-1453. PubMed ID: 28609567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2.
    Mathiesen JM; Christopoulos A; Ulven T; Royer JF; Campillo M; Heinemann A; Pardo L; Kostenis E
    Mol Pharmacol; 2006 Apr; 69(4):1441-53. PubMed ID: 16418339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.
    Oliver ET; Chichester K; Devine K; Sterba PM; Wegner C; Vonakis BM; Saini SS
    Int Arch Allergy Immunol; 2019; 179(1):21-30. PubMed ID: 30879003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils.
    Böhm E; Sturm GJ; Weiglhofer I; Sandig H; Shichijo M; McNamee A; Pease JE; Kollroser M; Peskar BA; Heinemann A
    J Biol Chem; 2004 Feb; 279(9):7663-70. PubMed ID: 14668348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.
    Gyles SL; Xue L; Townsend ER; Wettey F; Pettipher R
    Immunology; 2006 Nov; 119(3):362-8. PubMed ID: 17067313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor.
    Ishizuka T; Matsui T; Okamoto Y; Ohta A; Shichijo M
    Cardiovasc Drug Rev; 2004; 22(2):71-90. PubMed ID: 15179446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
    Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
    J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma.
    Kuna P; Bjermer L; Tornling G
    Drug Des Devel Ther; 2016; 10():2759-70. PubMed ID: 27621597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setipiprant, a selective oral antagonist of human CRTH2: relative bioavailability of a capsule and a tablet formulation in healthy female and male subjects.
    Baldoni D; Mackie A; Gutierrez M; Theodor R; Dingemanse J
    Clin Ther; 2013 Nov; 35(11):1842-8. PubMed ID: 24095247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
    Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A
    Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.